7621 - 7630 of 9038 Results
Title
Year
- New Questions About a Mysterious Neurologic Cluster in Canada2021RESTRICTEDTitle: New Questions About a Mysterious Neurologic Cluster in CanadaJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000792776.14362.2bCitation Count: 0
- Back to the Office2022RESTRICTEDTitle: Back to the OfficeJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 3Start Page: 28End Page: 31Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000834412.51769.b3Citation Count: 0
- Then and Now: 20 Years of Monumental Strides in Movement Disorders2021RESTRICTEDTitle: Then and Now: 20 Years of Monumental Strides in Movement DisordersJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 19Start Page: 8End Page: 10Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000797984.85450.f1Citation Count: 0
- For Some Neurologists, COVID-19 Has Prompted an ‘Existential Crisis’2021RESTRICTEDTitle: For Some Neurologists, COVID-19 Has Prompted an ‘Existential Crisis’Journal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805196.94665.beCitation Count: 0
- How to Increase Diverse Representation in Parkinson's Disease Trials2021RESTRICTEDTitle: How to Increase Diverse Representation in Parkinson's Disease TrialsJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page: 20End Page: 22Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805216.68841.48Citation Count: 0
- Could Soluble Amyloid Be Neuroprotective Rather Than Toxic?2021RESTRICTEDTitle: Could Soluble Amyloid Be Neuroprotective Rather Than Toxic?Journal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000792796.54034.5fCitation Count: 0
- New Insights from a Two-Country Study Comparing Escalation Strategies for MS Drugs2021RESTRICTEDTitle: New Insights from a Two-Country Study Comparing Escalation Strategies for MS DrugsJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 19Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000797988.61856.80Citation Count: 0
- MS Study That Spans Decades Indicates Patients Benefit from Early Diagnosis and Treatment2021RESTRICTEDTitle: MS Study That Spans Decades Indicates Patients Benefit from Early Diagnosis and TreatmentJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805208.98399.94Citation Count: 0
- Levodopa-Induced Dyskinesia in Parkinson Disease Specifically Associates With Dopaminergic Depletion in Sensorimotor-Related Functional Subregions of the Striatum2021OPENTitle: Levodopa-Induced Dyskinesia in Parkinson Disease Specifically Associates With Dopaminergic Depletion in Sensorimotor-Related Functional Subregions of the StriatumJournal Name: Clinical Nuclear MedicinePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 46Issue #: 6Start Page: e296End Page: e306Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/rlu.0000000000003609Citation Count: 7
- Editorial introductions2021RESTRICTEDTitle: Editorial introductionsJournal Name: Current Opinion in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 34Issue #: 1Start Page: viiEnd Page: viiiPublication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wco.0000000000000898Citation Count: 0